Last reviewed · How we verify

NCT05623553

Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican Population

Completed NA Last updated 21 November 2022
What this trial tests

NA trial testing Picterus Jaundice Pro in Jaundice, Neonatal in 174 participants. Completed in 8 August 2018.

Timeline
1 July 2018
Primary endpoint
11 July 2018
8 August 2018

Quick facts

Lead sponsorPicterus AS
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment174
Start date1 July 2018
Primary completion11 July 2018
Estimated completion8 August 2018
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Picterus AS

Who can join

Adults 0 Days to 14 Days, any sex, with Jaundice, Neonatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This corss-sectional study aims to test the performance and accuracy of the Picterus JP screening device in newborns with different skin types.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Picterus Jaundice Pro

Trials testing the same drug.

Other recruiting trials for Jaundice, Neonatal

Currently open trials in the same condition.

Other Picterus AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05623553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing